Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BRCA1 Mutation Carrier”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01772979
What this trial is testing

Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer

Who this might be right for
BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype
Catholic University of the Sacred Heart 100
Early research (Phase 1)Study completedNCT01339650
What this trial is testing

Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian TubePrimary Peritoneal CancerSolid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian
AbbVie (prior sponsor, Abbott) 93
Testing effectiveness (Phase 2)Study completedNCT00580112
What this trial is testing

An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 127
Not applicableUnknownNCT05409222
What this trial is testing

Study of Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2 Mutation Carriers (BRCA-HRT)

Who this might be right for
Hereditary Breast and Ovarian Cancer
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 45
Not applicableLooking for participantsNCT07253051
What this trial is testing

BRCA Mutation Carriers' Platform a Multicenter Study

Who this might be right for
BRCA1 MutationBRCA2 Mutation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 10,000
Not applicableLooking for participantsNCT07532434
What this trial is testing

A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer

Who this might be right for
Ovarian CancerBreast Cancer
Peking University Third Hospital 480
Large-scale testing (Phase 3)Study completedNCT00673335
What this trial is testing

Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
UNICANCER 170
Not applicableUnknownNCT02516540
What this trial is testing

Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers

Who this might be right for
Hereditary Breast and Ovarian Cancer
Technical University of Munich 600
Not applicableStudy completedNCT01097278
What this trial is testing

S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer
SWOG Cancer Research Network 208
Testing effectiveness (Phase 2)Study completedNCT01367639
What this trial is testing

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

Who this might be right for
Hereditary Breast and Ovarian Cancer Syndrome
Sheba Medical Center 67
Not applicableLooking for participantsNCT07197723
What this trial is testing

Study of How People Make Decisions About Prostate Cancer Risk

Who this might be right for
BRCA1/2Geneitic Testing
Memorial Sloan Kettering Cancer Center 150
Not applicableActive Not RecruitingNCT04499534
What this trial is testing

BRCA1/2 Flu Vaccine

Who this might be right for
BRCA1 MutationBRCA2 Mutation
Abramson Cancer Center at Penn Medicine 50
Testing effectiveness (Phase 2)Study completedNCT00664781
What this trial is testing

Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
Cancer Research UK 78
Not applicableWithdrawnNCT00899145
What this trial is testing

Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

Who this might be right for
BRCA1 Mutation CarrierBRCA2 Mutation CarrierBreast Carcinoma
Gynecologic Oncology Group
Not applicableActive Not RecruitingNCT04613440
What this trial is testing

FaCT Trial (Facilitated Cascade Testing Trial)

Who this might be right for
BRCA1 MutationBRCA2 Mutation
Weill Medical College of Cornell University 524
Not applicableStudy completedNCT00986206
What this trial is testing

Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierOvarian Cancer
Women and Infants Hospital of Rhode Island 525
Testing effectiveness (Phase 2)Study completedNCT02314156
What this trial is testing

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

Who this might be right for
BRCA1 Mutation CarrierBRCA2 Mutation CarrierDuctal Breast Carcinoma In Situ+6 more
Northwestern University 67
Early research (Phase 1)UnknownNCT01022333
What this trial is testing

The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers

Who this might be right for
Breast Cancer
Women's College Hospital 300
Not applicableUnknownNCT04038905
What this trial is testing

The Use of Digital Genetic Counselor (DGC) for BRCA1/2 Mutation Carrier Testing

Who this might be right for
BRCA Mutations
Igentify Ltd 300
Early research (Phase 1)Ended earlyNCT01233505
What this trial is testing

Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adenocarcinoma of the PancreasAdenocarcinoma of the StomachBRCA1 Mutation Carrier+23 more
National Cancer Institute (NCI) 16
Next Page